Cumulative radiation dose from medical imaging in kidney transplant patients

Nephrology Dialysis Transplantation

Volumn 27, Issue 9, 2012, Pages 3645-3651

  De Mauri, Andreana ^a   Brambilla, Marco ^a   Izzo, Cristina ^a   Matheoud, Roberta ^a   Chiarinotti, Doriana ^a   Carriero, Alessandro ^a   Stratta, Piero ^a   De Leo, Martino ^a  

^a University Hospital Maggiore della Carita   (Italy)

Author keywords

cancer risk; kidney transplant; medical imaging; radiation dose

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CUMULATIVE RADIATION DOSE; DESCRIPTIVE RESEARCH; DIAGNOSTIC IMAGING; DOSIMETRY; FEMALE; GRAFT RECIPIENT; HIGH RISK PATIENT; HUMAN; IONIZING RADIATION; ISCHEMIC HEART DISEASE; ITALY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOLOGICAL PARAMETERS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; DIAGNOSTIC IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RADIATION DOSAGE; RADIATION, IONIZING; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84865706550     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs145     Document Type: Article

References (38)

1. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
2. Laupacis A, Keown P, Pus N et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50: 235-242.
3. Loubeau PR, Loubeau JM, Jantzen R. The economics of kidney transplantation versus hemodialysis. Prog Transplant 2011; 11: 291-297.
4. Meier-Kriesche HU, Schold JD, Srinivas TR et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378-383.
5. Magee CC, Pascual M. Update in renal transplantation. Arch Intern Med 2004; 164: 1373-1388.
6. Excerpts from the United States Renal Data System. 2008 Annual Data reports: atlas of chronic kidney disease & end stage renal disease in the United States. Am J Kidney Dis 2009; 53: S1-S373.
7. Cura M, Elmerhi F, Bugnogne A et al. Renal aneurysms and pseudoaneurysms. Clin Imaging 2011; 35: 29-41.
8. Szabo Z, Alachkar N, Xia J et al. Molecular images of the kidneys. Semin Nucl Med 2011; 41: 20-28.
9. Reuter S, Schnöckel U, Edemir B et al. Potential of noninvasive serial assessment of acute renal allograft rejection by 18F-FDG PET to monitor treatment efficiency. J Nucl Med 2010; 51: 1644-1652.
10. Committee to assess health risks form exposure to low levels of ionizing radiation, National Research Council. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII-Phase 2. Washington, DC: National Academies Press, 2005.
11. Brenner DJ, Hall EJ, Phil D. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007; 357: 2277-2284.
12. Berrington de Gonzales A, Mahesh M, Kim K et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med 2009; 169: 2071-2077.
13. Vajdic CM, McDonald SP, McCredie MR et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823-2831.
14. Stewart JH, Vajdic CM, van Leeuwen MT et al. The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant 2009; 24: 3225-3231.
15. Fazel R, Krumholz HM, Wang Y et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 2009; 361: 849-857.
16. Mettler FA, Huda W, Yoshizumi TT et al. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology 2008; 248: 254-263.
17. Hart D, Wall BF. Effective Radiation Exposure of the UK Population from Medical and Dental X-ray Examinations. Oxon, UK: NRPNW4, 2002.
18. Smith-Bindman R, Lipson J, Marcus R et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 2009; 169: 2078-2086.
19. ICRP publication 103. The 2007 recommendations of the International Commission on radiological protection. Ann ICRP 2007; 37: 1-332.
20. Hart D, Wall BF. A survey of nuclear medicine in the UK in 2003/04. HPA-RPD-003. Chilton, England: Health Protection Agency, 2005.
21. ICRP publication 80. Radiation dose to patients from radiopharmaceuticals. Addendum 2 to ICRP 53. Also includes addendum 1 to ICRP publication 72. Ann ICRP 1998; 28: 1-130.
22. Little MP, Wakeford R, Tawn EJ et al. Risks associated with low doses and low dose rates of ionizing radiation: why linearity may be (almost) the best we can do. Radiology 2009; 251: 6-12.
23. Preston DL, Shimizu Y, Pierce DA et al. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 2003; 160: 381-407.
24. Pierce DA, Shimizu Y, Preston DL et al. Studies of the mortality of atomic bomb survivors. Report 12, part I. Cancer: 1950-1990. Radiat Res 1996; 146: 1-27.
25. Webster AC, Craig JC, Simpson JM et al. Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15183 Recipients. Am J Transplant 2007; 7: 2140-2151.
26. Goldblum SE, Reed WP. Host defense and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 1980; 93: 597-613.
27. Malachi T, Zevin D, Gafter U et al. DNA repair and recovery of RNA synthesis in uremic patients. Kidney Int 1993; 44: 385-389.
28. Marple JT, MacDougall M, Chonko AM. Renal cancer complicating acquired cystic kidney disease. J Am Soc Nephrol 1994; 4: 1951-1956.
29. Travis LB, Curtis RE, Glimelius B et al. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst 1995; 87: 524-530.
30. Silman AJ, Petrie J, Hazleman B et al. Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study. Ann Rheum Dis 1998; 47: 988-992.
31. Pickens DR, Sandler MP. Radiation exposure in dialysis patients. JASN 2011; 78: 724-725.
32. Stein EG, Haramati LB, Bellin E et al. Radiation exposure form medical imaging in patients with chronic and recurrent conditions. J Am Coll Radiol 2010; 7: 351-359.
33. Kroeker KI, Lam S, Birchall I et al. Patients with IBD are exposed to high levels of ionizing radiation through CT scan diagnostic imaging: a five-year study. J Clin Gastroenterol 2011; 45: 34-39.
34. Chen J, Einstein AJ, Fazel R et al. Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: a population-based analysis. J Am Coll Cardiol 2010; 56: 702-711.
35. Einstein AJ, Weiner SD, Berheim A et al. Multiple testing, cumulative radiation dose, and clinical indications in patients undergoing myocardial perfusion imaging. JAMA 2010; 304: 2137-2144.
36. Lawler PR, Afilalo J, Eisenberg MJ et al. Exposure to low-dose ionizing radiation from cardiac imaging among patients with myocardial infarction. Am J Cardiol 2012; 109: 31-35.
37. De Mauri A, Brambilla M, Chiarinotti D et al. Estimated radiation exposure from medical imaging in hemodialysis patients. J Am Soc Nephrol 2011; 22: 571-578.
38. Coyle J, Kinsella S, McCarthy S et al. Cumulative ionizing radiation exposure in patients with end stage kidney disease: a 6-year retrospective analysis. Abdom Imaging 2011; epub ahead of print.